Pentobarbital will minimize the level or outcome of alfentanil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known. pentobarbital will decrease the level or outcome of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar. Contraindicated. Coadministration of doravirine with a strong CYP3A inducer may less... https://davem012tgx9.azzablog.com/profile